• Scope of the Problem
• 34 min
  1. Cancer pain

  • Prof. Judith Paice
• Current Therapies
• 58 min
  2. The rational use of opioid analgesics for cancer pain - with a critique of the WHO 3-step ladder

  • Prof. Sam Ahmedzai
• 17 min
  3. Spinal analgesia for cancer pain

  • Prof. Jon Raphael
• 41 min
  4. Celiac plexus block

  • Prof. David Brown
• Future Directions
• 45 min
  5. Pain and symptom control in palliative care: new ways to think about old drugs

  • Prof. Larry Driver
• 36 min
  6. Symptom control: using technology pragmatically

  • Dr. Steven Richeimer
• From Palliative Care to Chronic Pain
• 42 min
  7. Insight and responsibility: ethics in pain medicine and palliative care

  • Prof. Rollin Gallagher
• 23 min
  8. The patient with pain: a palliative care approach

  • Dr. Janet Abrahm
• Archived Lectures *These may not cover the latest advances in the field
• 34 min
  9. Cancer pain and related symptoms: an overview

  • Prof. Judith Paice
• 74 min
  10. Cancer pain control: an evidence-based approach

  • Prof. Daniel Carr
  • Dr. Baraa Tayeb
• 47 min
  11. Optimal treatment of chronic pain

  • Prof. Gordon Irving
• 33 min
  12. Chronic cancer pain: the price of success?

  • Prof. Allen Burton

Printable Handouts

PDF

Navigable Slide Index

1. Introduction
2. Consequences of chronic pain
3. Dealing with the chronic pain patient
4. Integrating care: what are the problems?
5. Recognizing co-morbidities: sleep
6. Treating sleep disturbance
7. Psychiatric co-morbidity and chronic low back pain
8. Alcohol abuse
9. Identifying psychiatric problems
10. "Psychiatric sedimentation rate"
11. Recognizing major depression: 3 core symptoms
12. Psychopathology co-morbidities
13. Solutions to psychopathology problems
14. Stages of change (1)
15. Stages of change (2)
16. Personality traits
17. Personality traits: dependent clingers
18. Dependent clingers: treatment strategies
19. Dramatizing, emotional, histrionic patients
20. Dramatizing patients: treatment strategies
21. Personality traits: long suffering, self sacrificing
22. Long suffering, self sacrificing: treatment strategies
23. Personality traits: borderline personality
24. Borderline personality: treatment strategies
25. The angry patient: treatment strategies
26. How to change a patient from victim to coping
27. Goal setting
28. Integrating care: practitioner attitude
29. Integrating care: physical setting
30. The pain examination
31. Follow up: touch
32. Follow up: examination
33. Integrating care: empathy
34. Developing a plan: what are the problems?
35. Pain education web sites
36. Neuropathic pain: treatment algorithm
37. Opioid phobia
38. Opioids: basics
39. Opioids effects on function
40. Opioids: chronic pain
41. Prescribing opioids (1)
42. Integrating practice: opioid refill policy
43. Opioids: common and emerging side effects
44. Opioid-induce hyperalgesia
45. Prescribing opioids (2)
46. Tapering opioids
47. Potential support of complementary practitioners
48. Chronic pain: nonpharmacologic management
49. Steps to exercise
50. Evidence for the benefit of exercise
51. Physical therapy/chiropracty
52. Complementary practitioners: who to suggest?
53. Complementary medicine: rheumatoid arthritis
54. Web sites for complementary medicine
55. Lack of a plan and failure to stick to it
56. The plan
57. Coordination of the multidisciplinary team

Topics Covered

• Dealing with the difficult and complex non-malignant pain patient
• It is important to recognize both psychosocial and psychiatric co-morbidities
• Having the patient become part of the solution and having them set realistic goals is important
• Drugs used are similar to those used for cancer pain management but greater awareness of long term effects of opioids such as hyperalgesia and immune suppression, as well as diversion is important

Links

Series:

• Cancer Pain Management

Categories:

• Cancer
• Neuroscience

Therapeutic Areas:

• Neurology
• Oncology

Talk Citation

Publication History

• Published on February 23, 2009
• Archived on February 25, 2021

Financial Disclosures

• Prof. Gordon Irving has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.